Screening for Tumor Microtube–Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression

Cancers can hijack neural properties to grow, disseminate, and to resist therapies, but effective drug development pipelines against these features are missing. Here, we establish a compound screening approach that allowed the identification of PKC modulators that target cancer cell-intrinsic neurodevelopmental mechanisms, suggesting a new class of neuroscience-instructed cancer therapeutics.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2025-10-09
DOI
https://doi.org/10.1158/2159-8290.cd-24-0414
Citations
1
Primary Topic
Microtubule and mitosis dynamics
Type
article
Field-Weighted Citation Impact
1.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Screening for Tumor Microtube–Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression

Matthia A. Karreman, Frank Winkler, Gina Cebulla, Pino Bordignon et al.
1 citations
Cancer Discovery
Microtubule and mitosis dynamics
1.15
article

Screening for Tumor Microtube–Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression

Matthia A. Karreman, Frank Winkler, Gina Cebulla, Pino Bordignon, Dirk C. Hoffmann, Anna Kreshuk, Denise Reibold, Nils Hebach, Susann Wendler, Ammar Jabali, Jill Reckless, Andreas E. Moor, Tim Holland‐Letz, Nigel G. Ramsden, David Hausmann, Matthias Osswald, Rajiv K. Khajuria, David J. Grainger, Philipp Koch, Sandra Horschitz, Cathrin Löb, Pascal Lehnert, Wolfgang Wick, Erik Jung, Chanté D. Mayer, Ling Hai, Miriam Ratliff, Tobias Keßler, Daniel Domínguez Azorín, Sophie Heuer
article en
1 citations

Abstract

Cancers can hijack neural properties to grow, disseminate, and to resist therapies, but effective drug development pipelines against these features are missing. Here, we establish a compound screening approach that allowed the identification of PKC modulators that target cancer cell-intrinsic neurodevelopmental mechanisms, suggesting a new class of neuroscience-instructed cancer therapeutics.

Cancer DiscoveryVol. 16(2)
German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), ETH Zurich (CH), Praxis (United Kingdom) (GB), Central Institute of Mental Health (DE), National Center for Tumor Diseases (DE), Hexcel (United Kingdom) (GB), Centro Medico Nacional Siglo XXI (MX), The Taiwanese Osteoporosis Association (TW), Medication Management (United States) (US), Dexcel Pharma (United Kingdom) (GB), European Molecular Biology Laboratory (DE), Hertie Institute for Clinical Brain Research (DE), Moximed (United States) (US), European Molecular Biology Laboratory (DE), University Medical Centre Mannheim (DE)
Openalex Percentile: Top 19%
Microtubule and mitosis dynamics
1.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.